Novel Molecules for Precision Oncology

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 279

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

This is the 2nd edition of the Special issue “Novel Molecules for Cancer Treatment” (https://www.mdpi.com/journal/biomolecules/special_issues/Novel_Molecules). Cancer can appear anywhere in the body, due to uncontrolled cell proliferation, inhibition of apoptosis and an increased cell migration. Tumor cells are able to activate thorough mechanisms to generate a tumor from early stages to develop metastases through the induction of angiogenesis and an immunosuppressive microenvironment. Other crucial events in tumorigenesis are the emergence of the undifferentiated phenotype and the generation and maintenance of cancer stem cells. In carcinogenesis, the co-activation of several genes and pathways is common, and the study of these factors and signaling pathways has greatly helped to identify new targets for drug design. These drugs could be chemically synthesized or isolated from natural substances. These novel molecules represent a massive step forward in reaching personalized medicine in the present clinical practice.

In this Special Issue entitled "Novel Molecules for Cancer Treatment", we encourage authors to submit high-quality research articles dealing with novel biomolecules, and provide a strong evidence of their anti-tumor potential activity to the scientific and clinical community. This activity could be observed both in solid tumors or in hematological malignancies, and be evaluated with in vitro and/or in vivo models. On the other hand, we are open to receiving updated reviews about novel molecules or treatment strategies based on synthetic or natural compounds, which could provide a rationale for further clinical oncology research.

I look forward to receiving your manuscripts.

Dr. Javier Martinez Useros
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop